-
公开(公告)号:JP2000023678A
公开(公告)日:2000-01-25
申请号:JP3476299
申请日:1999-02-12
Applicant: BASF AG
Inventor: KROEGER BURKHARD DR
IPC: C12N15/09 , A61K38/55 , A61K48/00 , C12N5/10 , C12N15/00 , C12N15/55 , C12N15/57 , C12R1/91 , C07K16/40 , C12N1/10 , C12N1/15 , C12N1/19 , C12N1/21 , C12N9/50 , C12Q1/68 , G01N33/53
Abstract: PROBLEM TO BE SOLVED: To obtain a new serine protease protein which contains a specific amino acid sequence, consists of a serine protease protein arising from prostata and is useful for diagnosis, treatment or the like for diseases of prostata and genital system, e.g. prostatic hypertrophy, prostatic cancer, breast cancer, spermatheca disease and the like. SOLUTION: This protein is a new serine protease protein arising from prostata, which is composed of the isolated protein containing the amino acid sequence represented by the formula or the protein obtained by substituting, inserting or deleting at least one amino acid residues from the isolated protein and contains the sequence having at least one of main biological specific characteristics of the protein represented by the formula, and is useful in the diagnosis or the treatment for disease of prostata or genital system and in the diagnosis or the treatment for spermatheca disease, breast cancer, prostatic cancer and prostatic hypertrophy or its metastasis. This protein is prepared by introducing an expression system obtained by integrating a nucleotide sequence that codes for serine protease identified by a cDNA library from human prostata into host cells to transform and then cultivating this.
-
公开(公告)号:JPH11318452A
公开(公告)日:1999-11-24
申请号:JP3149799
申请日:1999-02-09
Applicant: BASF AG
Inventor: KROEGER BURKHARD DR , OTTERBACH BERND DR
IPC: C12N15/09 , A61K48/00 , C07K14/705 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/00 , C12N15/12 , C12P21/02 , C12P21/08 , C12Q1/02 , C12Q1/68 , C12R1/91 , G01N33/15 , G01N33/53 , G01N33/566
Abstract: PROBLEM TO BE SOLVED: To obtain an isolated protein having an activity as a G protein-coupled receptor and useful for the treatment of diseases, etc., in the central nervous system or the peripheral nervous system such as Alzheimer disease by providing a specific amino acid sequence. SOLUTION: This receptor is a human protein having an amino acid sequence represented by the formula or a sequence in which one or more amino acid residues are substituted, inserted or deleted therefrom and retaining one or more main biological characteristics of the protein represented by the formula at that time. A cell having the protein on the cell surface is preferably combined with many substances to be investigated and the biological activity of the receptor is then compared in the presence (absence) of the substances to be tested to identify an antagonist and an agonist of the protein. A biological sample together with an antibody specifically to the protein is kept at a constant temperature to detect an antibody/antigen complex. The amount of the antibody/ antigen complex is preferably compared with the standard to qualitatively and quantitatively detect the protein in the biological sample.
-
公开(公告)号:JPH11160314A
公开(公告)日:1999-06-18
申请号:JP27147598
申请日:1998-09-25
Applicant: BASF AG
Inventor: EIPEL HEINZ , KELLER HARALD DR , KROEGER BURKHARD DR , PHILIPP SABINE DR
IPC: G01N31/22 , G01N33/52 , G01N33/543 , G01N33/551
Abstract: PROBLEM TO BE SOLVED: To provide an analytical measuring method and its use. SOLUTION: In an analytical measuring method, a reagent singly or a mixture of a reagent is individually applied to hydrophilic measurement zones 1 on a base material 5. The base material 5 is treated with at least one type of reagent common to all the measurement zones to add the reagent to the hydrophilic measurement zones 1. The measurement zones are cleaned after the application of the reagent or after the mutual reaction time of the reagents has elapsed depending on the case. and the measurement zones are measured together or singly. This method is used for a diagnosing method, the examination and of active substances, combinatorial chemistry, crop protection, toxicology, or environmental protection.
-
公开(公告)号:DE19742246A1
公开(公告)日:1999-04-01
申请号:DE19742246
申请日:1997-09-25
Applicant: BASF AG
Inventor: EIPEL HEINZ , KELLER HARALD DR , KROEGER BURKHARD DR , PHILIPP SABINE DR
IPC: G01N31/22 , G01N33/52 , G01N33/543 , G01N33/551
-
公开(公告)号:DE4403665A1
公开(公告)日:1995-08-10
申请号:DE4403665
申请日:1994-02-07
Applicant: BASF AG
Inventor: KROEGER BURKHARD DR , SEULBERGER HARALD DR , SUBKOWSKI THOMAS DR , HILLEN HEINZ DR , JACOB ELARD DR , MEYER THOMAS DR , OTTER RAINER DR , SCHMIDT MARTIN DR
Abstract: An endothelin converting enzyme (ECE) having the 754 (bovine) or 753 (human) amino acid sequence shown in the specification, or functional fragments, is new. Also claimed is DNA defined as (a) coding for the ECE as above, (b) having the 2314 (bovine) or 2720 (human) nucleotide sequence given in the specification or complementary sequences, or (c) encoding proteins which are recognised by antibodies generated against ECE as above.
-
公开(公告)号:AT284536T
公开(公告)日:2004-12-15
申请号:AT98118034
申请日:1998-09-23
Applicant: BASF AG
Inventor: EIPEL HEINZ , KELLER HARALD DR , KROEGER BURKHARD DR , PHILIPP SABINE DR
IPC: G01N31/22 , G01N33/52 , G01N33/543 , G01N33/551
-
公开(公告)号:DE19805351A1
公开(公告)日:1999-08-12
申请号:DE19805351
申请日:1998-02-11
Applicant: BASF AG
Inventor: KROEGER BURKHARD DR , OTTERBACH BERND DR
IPC: C12N15/09 , A61K48/00 , C07K14/705 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/00 , C12N15/12 , C12P21/02 , C12P21/08 , C12Q1/02 , C12Q1/68 , C12R1/91 , G01N33/15 , G01N33/53 , G01N33/566 , C07K16/00 , C07H21/04 , C07K14/435 , C12N1/00 , C12N15/11 , C12Q1/00 , G01N33/68
Abstract: An isolated protein or its derivative (I) is new and has a 481 amino acid sequence given in the specification Independent claims are also included for the following: (1) a nucleic acid sequence (II) encoding (I); (2) recombinant constructs (IIa) comprising (II) plus regulatory elements; (3) host cells transformed with (II) or (IIa); (4) antibodies (Ab) specific for (I); (5) a method for identifying ligands of (I); and (6) methods for quantitative or qualitative determination of (I) and (II) in biological samples.
-
公开(公告)号:DE4341078A1
公开(公告)日:1995-06-08
申请号:DE4341078
申请日:1993-12-02
Applicant: BASF AG
Inventor: KROEGER BURKHARD DR , BIALOJAN SIEGFRIED DR
IPC: C12Q1/68 , C12Q1/6897 , C12Q1/66
Abstract: Identification of substances (A) that inhibit expression of plasminogen activator inhibitor-1 (I) comprises: (i) transfecting a host cell with a recombinant vector that contains a regulatory region of the (I) gene functionally attached to a reporter gene (RG); (ii) either (iia) establishing a cell line that transiently contains the vector or (iib) growing a cell line that has stably integrated the vector; (3) treating the cell lines of either sort with test cpds.; and (4) measuring expression of RG.
-
公开(公告)号:DE4427394A1
公开(公告)日:1996-02-08
申请号:DE4427394
申请日:1994-08-03
Applicant: BASF AG
Inventor: BIALOJAN SIEGFRIED DR , KROEGER BURKHARD DR
IPC: C12Q1/68 , C12Q1/6897 , C12Q1/66 , G01N33/53
Abstract: Method for identifying substances (I) that act on the serotonin 5HT-1D receptor (A) comprises: (a) transfecting a host cell that recombinantly and stably expresses (A) with a recombinant vector contg.: (i) a promoter that is activated by elevation of the level of second messengers; and (ii) a functionally coupled reporter gene (RG); (b) establishing cells that transiently contain, or have stably integrated, the vector; (c) exposing these cells to test cpd.; and (d) measuring expression of RG.
-
公开(公告)号:DE4411225A1
公开(公告)日:1995-10-05
申请号:DE4411225
申请日:1994-03-31
Applicant: BASF AG
Inventor: BAUMANN ERNST DR , VOGELBACHER UWE JOSEF DR , RHEINHEIMER JOACHM DR , KLINGE DAGMAR DR , RIECHERS HARTMUT DR , KROEGER BURKHARD DR , BIALOJAN SIEGFRIED DR , BOLLSCHWEILER CLAUS DR , WERNET WOLFGANG DR , UNGER LILIANE DR , RASCHACK MANFRED DR
IPC: C07D251/26 , A61K31/00 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The invention concerns the use of carboxylic acid derivatives of formula I (I) in which R means a formyl group, a CO2H group or a residue which can be hydrolysed to form COOH; X means nitrogen or CR , wherein R means hydrogen or, together with R , forms a 3- to 4-member alkylene or alkenylene chain in each of which a methyl group can be replaced by oxygen; Y means sulphur or oxygen or a single bond; Z means sulphur or oxygen; and the other substituents have the meanings given in the description. These derivatives can be used for preparing medicaments.
-
-
-
-
-
-
-
-
-